NASDAQ:DCPH - Deciphera Pharmaceuticals News Headlines

$36.08
-0.92 (-2.49 %)
(As of 08/21/2019 04:00 PM ET)
Today's Range
$35.89
Now: $36.08
$37.15
50-Day Range
$20.53
MA: $24.73
$38.39
52-Week Range
$18.55
Now: $36.08
$42.99
Volume526,500 shs
Average Volume361,861 shs
Market Capitalization$1.38 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.34

Headlines

Deciphera Pharmaceuticals (NASDAQ DCPH) News Headlines

Source:
DateHeadline
Deciphera Presses Forward Towards NDA Filing After Positive Data And Large Cash RaiseDeciphera Presses Forward Towards NDA Filing After Positive Data And Large Cash Raise
seekingalpha.com - August 20 at 11:22 PM
Deciphera Pharmaceuticals: Updates To Thesis, Further Upside Ahead Post Phase 3 WinDeciphera Pharmaceuticals: Updates To Thesis, Further Upside Ahead Post Phase 3 Win
seekingalpha.com - August 20 at 6:22 PM
Insider Selling: Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Major Shareholder Sells 350,000 Shares of StockInsider Selling: Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Major Shareholder Sells 350,000 Shares of Stock
www.americanbankingnews.com - August 19 at 8:47 PM
Deciphera closes $400M capital raiseDeciphera closes $400M capital raise
seekingalpha.com - August 19 at 6:09 PM
Deciphera Pharmaceuticals Announces Closing of Public Offering of Common StockDeciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock
finance.yahoo.com - August 19 at 6:09 PM
 Analysts Expect Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Will Post Earnings of -$1.18 Per Share Analysts Expect Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Will Post Earnings of -$1.18 Per Share
www.americanbankingnews.com - August 19 at 4:08 AM
Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Forecasted to Earn FY2019 Earnings of ($4.22) Per ShareDeciphera Pharmaceuticals Inc (NASDAQ:DCPH) Forecasted to Earn FY2019 Earnings of ($4.22) Per Share
www.americanbankingnews.com - August 19 at 2:30 AM
FY2019 Earnings Forecast for Deciphera Pharmaceuticals Inc Issued By Svb Leerink (NASDAQ:DCPH)FY2019 Earnings Forecast for Deciphera Pharmaceuticals Inc Issued By Svb Leerink (NASDAQ:DCPH)
www.americanbankingnews.com - August 19 at 2:30 AM
Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Given Consensus Recommendation of "Buy" by BrokeragesDeciphera Pharmaceuticals Inc (NASDAQ:DCPH) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - August 18 at 12:49 PM
Decipheras GIST Drug Succeeds in Pivotal Study, Stock Up 80%Deciphera's GIST Drug Succeeds in Pivotal Study, Stock Up 80%
finance.yahoo.com - August 15 at 5:50 PM
Deciphera Pharmaceuticals: Upsized Offering Indicates Heightened Demand For The StockDeciphera Pharmaceuticals: Upsized Offering Indicates Heightened Demand For The Stock
seekingalpha.com - August 15 at 5:50 PM
Deciphera prices stock offering at $37Deciphera prices stock offering at $37
seekingalpha.com - August 15 at 8:29 AM
Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common StockDeciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - August 14 at 11:01 PM
This Biotech Is On A Two-Day Sprint; Why An Analyst Prefers Its RivalThis Biotech Is On A Two-Day Sprint; Why An Analyst Prefers Its Rival
finance.yahoo.com - August 14 at 6:01 PM
Deciphera Pharmaceuticals (NASDAQ:DCPH) Price Target Raised to $60.00 at SunTrust BanksDeciphera Pharmaceuticals (NASDAQ:DCPH) Price Target Raised to $60.00 at SunTrust Banks
www.americanbankingnews.com - August 14 at 4:03 PM
Deciphera Pharmaceuticals (NASDAQ:DCPH) Stock Rating Reaffirmed by Leerink SwannDeciphera Pharmaceuticals (NASDAQ:DCPH) Stock Rating Reaffirmed by Leerink Swann
www.americanbankingnews.com - August 14 at 9:41 AM
Deciphera Pharmaceuticals (NASDAQ:DCPH) Receives "Overweight" Rating from Cantor FitzgeraldDeciphera Pharmaceuticals (NASDAQ:DCPH) Receives "Overweight" Rating from Cantor Fitzgerald
www.americanbankingnews.com - August 14 at 9:41 AM
Deciphera Pharmaceuticals (NASDAQ:DCPH) Receives "Positive" Rating from Canaccord GenuityDeciphera Pharmaceuticals (NASDAQ:DCPH) Receives "Positive" Rating from Canaccord Genuity
www.americanbankingnews.com - August 14 at 9:35 AM
Deciphera Pharmaceuticals stock more than doubles on heavy volume after positive trial dataDeciphera Pharmaceuticals stock more than doubles on heavy volume after positive trial data
www.marketwatch.com - August 13 at 11:25 PM
Insider Selling: Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) CFO Sells 11,250 Shares of StockInsider Selling: Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) CFO Sells 11,250 Shares of Stock
www.americanbankingnews.com - August 13 at 8:56 PM
Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Insider Daniel Lee Flynn Sells 148,107 SharesDeciphera Pharmaceuticals Inc (NASDAQ:DCPH) Insider Daniel Lee Flynn Sells 148,107 Shares
www.americanbankingnews.com - August 13 at 8:55 PM
Michael Douglas Taylor Sells 22,500 Shares of Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) StockMichael Douglas Taylor Sells 22,500 Shares of Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Stock
www.americanbankingnews.com - August 13 at 8:55 PM
Breakthrough Gastrointestinal Tumor Therapy Reaches New MilestoneBreakthrough Gastrointestinal Tumor Therapy Reaches New Milestone
247wallst.com - August 13 at 6:25 PM
Heres Why Deciphera Pharmaceuticals Rose as Much as 115% TodayHere's Why Deciphera Pharmaceuticals Rose as Much as 115% Today
www.fool.com - August 13 at 6:25 PM
Deciphera Soars on Positive Phase III Drug TrialDeciphera Soars on Positive Phase III Drug Trial
www.thestreet.com - August 13 at 6:25 PM
Deciphera stock surges on gastrointestinal cancer drug successDeciphera stock surges on gastrointestinal cancer drug success
www.bizjournals.com - August 13 at 6:25 PM
Deciphera readies $200M stock offeringDeciphera readies $200M stock offering
seekingalpha.com - August 13 at 6:25 PM
This Biotech Stock Rocketed 80% In Bullish Volume On A Cancer DrugThis Biotech Stock Rocketed 80% In Bullish Volume On A Cancer Drug
finance.yahoo.com - August 13 at 6:25 PM
Why Best Buy, Deciphera Pharmaceuticals, and Genworth Financial Jumped TodayWhy Best Buy, Deciphera Pharmaceuticals, and Genworth Financial Jumped Today
finance.yahoo.com - August 13 at 6:25 PM
Deciphera (DCPH) Stock at $62 a Share? Deutsche Bank Thinks It’s PossibleDeciphera (DCPH) Stock at $62 a Share? Deutsche Bank Thinks It’s Possible
finance.yahoo.com - August 13 at 6:25 PM
Deciphera Pharmaceuticals (NASDAQ:DCPH) Price Target Increased to $66.00 by Analysts at GuggenheimDeciphera Pharmaceuticals (NASDAQ:DCPH) Price Target Increased to $66.00 by Analysts at Guggenheim
www.americanbankingnews.com - August 13 at 5:40 PM
Apple, Mattel and JD.com rise while Covetrus fallsApple, Mattel and JD.com rise while Covetrus falls
marketbeat.com - August 13 at 5:13 PM
Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Short Interest Down 14.3% in JulyDeciphera Pharmaceuticals Inc (NASDAQ:DCPH) Short Interest Down 14.3% in July
www.americanbankingnews.com - August 13 at 12:27 PM
Deciphera Soars On Positive Readouts For Gastrointestinal Tumor DrugDeciphera Soars On Positive Readouts For Gastrointestinal Tumor Drug
feeds.benzinga.com - August 13 at 10:07 AM
Decipheras late-stage study meets main goal of preventing cancer progressionDeciphera's late-stage study meets main goal of preventing cancer progression
www.nasdaq.com - August 13 at 8:06 AM
Deciphera Pharmas late-stage stomach cancer study meets main goalDeciphera Pharma's late-stage stomach cancer study meets main goal
www.nasdaq.com - August 13 at 8:06 AM
Deciphera up 101% premarket on positive late-stage ripretinib dataDeciphera up 101% premarket on positive late-stage ripretinib data
seekingalpha.com - August 13 at 8:06 AM
Deciphera Pharmaceuticals Announces Positive Top-line Results from INVICTUS Pivotal Phase 3 Clinical Study of Ripretinib in Patients with Advanced Gastrointestinal Stromal TumorsDeciphera Pharmaceuticals Announces Positive Top-line Results from INVICTUS Pivotal Phase 3 Clinical Study of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors
finance.yahoo.com - August 13 at 8:06 AM
Deciphera Pharmaceuticals Reports Positive Updated Phase 1 Data for Ripretinib in Gastrointestinal Stromal TumorsDeciphera Pharmaceuticals Reports Positive Updated Phase 1 Data for Ripretinib in Gastrointestinal Stromal Tumors
finance.yahoo.com - August 13 at 8:06 AM
Deciphera Pharma's late-stage stomach cancer study meets main goalDeciphera Pharma's late-stage stomach cancer study meets main goal
finance.yahoo.com - August 13 at 8:06 AM
UPDATE 1-Deciphera's late-stage study meets main goal of preventing cancer progressionUPDATE 1-Deciphera's late-stage study meets main goal of preventing cancer progression
finance.yahoo.com - August 13 at 8:06 AM
Deciphera Pharmaceuticals Inc Expected to Earn Q3 2019 Earnings of ($1.37) Per Share (NASDAQ:DCPH)Deciphera Pharmaceuticals Inc Expected to Earn Q3 2019 Earnings of ($1.37) Per Share (NASDAQ:DCPH)
www.americanbankingnews.com - August 8 at 8:17 AM
Deciphera Pharmaceuticals (NASDAQ:DCPH) Announces  Earnings ResultsDeciphera Pharmaceuticals (NASDAQ:DCPH) Announces Earnings Results
www.americanbankingnews.com - August 3 at 4:27 PM
Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2019 Financial ResultsDeciphera Pharmaceuticals, Inc. Announces Second Quarter 2019 Financial Results
finance.yahoo.com - August 2 at 9:52 AM
Implied Volatility Surging for Deciphera (DCPH) Stock OptionsImplied Volatility Surging for Deciphera (DCPH) Stock Options
finance.yahoo.com - July 26 at 11:17 AM
Noteworthy Friday Option Activity: GOOGL, DCPH, ONBNoteworthy Friday Option Activity: GOOGL, DCPH, ONB
www.nasdaq.com - July 12 at 5:25 PM
Deciphera Pharmaceuticals, Inc. Announces Appointment of Susan L. Kelley, M.D., to its Board of DirectorsDeciphera Pharmaceuticals, Inc. Announces Appointment of Susan L. Kelley, M.D., to its Board of Directors
finance.yahoo.com - July 8 at 5:27 PM
Deciphera Pharmaceuticals, Inc. and Zai Lab Limited Announce an Exclusive License Agreement for Ripretinib in Greater ChinaDeciphera Pharmaceuticals, Inc. and Zai Lab Limited Announce an Exclusive License Agreement for Ripretinib in Greater China
finance.yahoo.com - June 24 at 5:38 PM
Options Traders Expect Huge Moves in Deciphera Pharmaceuticals (DCPH) StockOptions Traders Expect Huge Moves in Deciphera Pharmaceuticals (DCPH) Stock
finance.yahoo.com - June 18 at 6:04 PM
Zai Lab in-licenses ripretinib rights from DecipheraZai Lab in-licenses ripretinib rights from Deciphera
seekingalpha.com - June 11 at 10:26 AM
This page was last updated on 8/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel